NCT05879523View on ClinicalTrials.gov

A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

March 21, 2024

Study Completion Date

March 21, 2024

Conditions
Obstructive Hypertrophic Cardiomyopathy
Interventions
DRUG

HRS-1893

subcutaneous, single dose, multiple doses

DRUG

Placebo

subcutaneous, single dose, multiple doses

Trial Locations (1)

100029

Beijing Anzhen Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT05879523 - A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter